New York is currently home to 4790 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Recruiting
The purpose of this study is to learn more about the effects of (classification determinant) CD34+ stem cell selection on graft versus host disease (GVHD) in children, adolescents, and young adults. CD34+ stem cells are the cells that make all the types of blood cells in the body. GVHD is a condition that results from a reaction of transplanted donor T-lymphocytes (a kind of white blood cell) against the recipient's body and organs. Study subjects will be offered treatment involving the use of t... Read More
Gender:
All
Ages:
22 years and below
Trial Updated:
06/17/2020
Locations: Columbia University Medical Center, New York, New York
Conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
Recruiting
A phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when administered following induction chemotherapy, consolidation chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a 1:1 ratio to receive either crenolanib in addition to standard first line treatment of AML (chemotherapy and if eligible, transplantation) (arm A) or midostaurin and standard treat... Read More
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
05/21/2020
Locations: Montefiore Medical Center, Bronx, New York
Conditions: Newly Diagnosed FLT3 Mutated AML
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
Recruiting
The purpose of this study is to test the hypothesis that post-exposure prophylaxis with hydroxychloroquine will reduce the symptomatic secondary attack rate among household contacts of known or suspected COVID-19 patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2020
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: COVID-19, Corona Virus Infection
Pulmonary Hypertension Association Registry
Recruiting
The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care Centers throughout the U.S. PHAR will determine how people with PAH and CTEPH are evaluated, tested, and treated, and will observe how well these participants do. The goal is to see if people with PH a... Read More
Gender:
All
Ages:
All
Trial Updated:
04/01/2020
Locations: Weill Cornell Medical Center, New York, New York
Conditions: Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
Metformin in Heart Failure Without Diabetes
Recruiting
Columbia University Medical Center is conducting a pilot clinical research study that will assess the use of the medication metformin for heart failure in patients who are not diabetic and have no evidence of insulin resistance. Patients will received either the study drug metformin or placebo for 4 months. During the study, the patients will undergo extensive testing that will include symptom assesment, exercise capacity, echocardiography, cardiac PET imaging and blood tests.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/06/2020
Locations: New York Hospital - Columbia University Irving Medical Center, New York, New York
Conditions: Heart Failure
A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery
Recruiting
To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
Gender:
All
Ages:
Between 22 years and 100 years
Trial Updated:
12/17/2019
Locations: Ophthalmic Consultants of Long Island, Garden City, New York
Conditions: Patient Preference
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
Recruiting
The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).
Gender:
All
Ages:
21 years and above
Trial Updated:
12/04/2019
Locations: Mount Sinai, Icahn School of Medicine, New York, New York
Conditions: Mitral Valve Insufficiency
Evaluating Alcohol Use in Alcoholic Liver Disease
Recruiting
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/11/2019
Locations: New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center, New York, New York
Conditions: Alcoholic Liver Disease
The Drift-Reduction for Improved FFR Using Fiberoptic Technology (DRIFT) Study
Recruiting
The primary objective of this study is to assess the accuracy, efficacy, and durability of the OpSens Medical OptoWire Deux pressure wire in the assessment of angiographically intermediate proximal left anterior descending coronary artery (LAD) stenoses in clinical practice.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/19/2019
Locations: New York Presbyterian Hospital/Columbia University Medical Center, New York, New York
Conditions: Left Anterior Descending Coronary Artery Stenosis
MRI Predictors of Response to Tumor Treating Fields
Recruiting
Patients with glioblastoma, an aggressive brain tumor, are recommended to undergo treatment with tumor treating fields using the Optune device as part of standard of care therapy. While undergoing treatment, patients are monitored regularly with brain MRI scans to look for tumor progression, but there are currently no means to predict which, or when, patients will progress. The purpose of the current study is to prospectively analyze these MRI scans to look for subtle imaging markers that can pr... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/14/2018
Locations: New York Presbyterian - Brooklyn Methodist Hospital, Brooklyn, New York
Conditions: Glioblastoma Multiforme
Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)
Recruiting
Guanfacine may preferentially reduce craving and improve cognitive control in women with Alcohol Use Disorder (AUD), compared to men. As these behaviors are related to relapse, the objectives of this study are to conduct a 10-week out-patient clinical trial to examine the effects of Guanfacine Extended Release (XR; 3mgs) versus placebo on drinking measures in women with AUD.
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
09/04/2018
Locations: The Clinical Research Center, East Setauket, New York
Conditions: Alcohol Abstinence
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
Recruiting
This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/03/2016
Locations: Michael H. Tirgan, MD, New York, New York
Conditions: Keloid